Retraction: Dermokine mutations contribute to epithelial-mesenchymal transition and advanced melanoma through ERK/MAPK pathways
Format: | Article |
---|---|
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10965076/?tool=EBI |
Similar Items
-
Retraction: Dermokine mutations contribute to epithelial-mesenchymal transition and advanced melanoma through ERK/MAPK pathways.
by: PLOS ONE Editors
Published: (2024-01-01) -
Dermokine mutations contribute to epithelial-mesenchymal transition and advanced melanoma through ERK/MAPK pathways.
by: Wenqiong Ma, et al.
Published: (2023-01-01) -
CD147 promotes breast cancer migration and invasion by inducing epithelial-mesenchymal transition via the MAPK/ERK signaling pathway
by: Fang Li, et al.
Published: (2023-12-01) -
CLCA2 overexpression suppresses epithelial-to-mesenchymal transition in cervical cancer cells through inactivation of ERK/JNK/p38-MAPK signaling pathways
by: Wenhu Xin, et al.
Published: (2022-10-01) -
Mechanisms of RON-mediated epithelial-mesenchymal transition in MDCK cells through the MAPK pathway
by: Xu Xiangming, et al.
Published: (2011-07-01)